|

Comparison of Two Pulse Field Ablation Systems for AF Ablation

RECRUITINGN/ASponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Actively Recruiting
PhaseN/A
SponsorAllegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Started2026-07-10
Est. completion2028-08-30
Eligibility
Age18 Years – 89 Years
Healthy vol.Accepted
Locations1 site

Summary

This study randomizes patients undergoing PFA for A Fib to one of two standard care PFA systems. The patient will have an ICM placed to continuously monitor their heart rhythm. Follow up visits will occur until Month 36, and will include 12-lead ECG, ICM interrogation, AE updates, and QOL surveys.

Eligibility

Age: 18 Years – 89 YearsHealthy volunteers accepted
Inclusion Criteria:

* Symptomatic AF
* Persistent AF
* De novo AF ablation
* Males and Females Age 18 to 89 years of age, inclusive
* Willing and capable to provide informed consent
* Able and willing to participate in all examinations and follow-up visits and tests associated with this clinical study

Exclusion Criteria:

* AF secondary to electrolyte imbalance, thyroid disease, alcohol abuse, or other reversible/non-cardiac causes
* Contraindication to, or unwillingness to use, systematic anticoagulation
* Left ventricular ejection fraction LVEF 30% as documented by TTE (within 3 months prior)
* Left atrial volume index \>60 ml/m2
* LA anteroposterior dimension 5.5 cm
* Presence of intramural thrombus, tumor or other abnormality that precludes safe catheter introduction or manipulation
* BMI \>35 kg/m2
* Chronic renal insufficiency of \<15 mL/min/1.73 m2 or any history of renal dialysis, or history of renal transplant
* Clinically significant systemic infection or sepsis
* Any of the following within the 3-months prior to enrollment:

  * Myocardial infarction
  * Unstable angina
  * Percutaneous coronary intervention
  * Heart failure hospitalization
  * Stroke or TIA
  * Significant bleeding
  * Pericarditis/effusions
  * Left atrial thrombus
  * Coronary artery bypass grafting/atriotomy within 6 months prior
  * Contraindication for oral anticoagulation
  * Organ or hematologic transplant, or currently being evaluated for an organ transplant Women who are pregnant or breastfeeding

Conditions2

AF - Atrial FibrillationHeart Disease

Locations1 site

Allegheny General Hospital
Pittsburgh, Pennsylvania, 15212
Heather McDonald, MHA, CCRC412-359-3660heather.mcdonald@ahn.org

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.